Malvern & Leukocare collaborate on COVID-19 vaccines
Industry News: Malvern Panalytical & Leukocare collaborate on stabilization and formulation development of COVID-19 vaccines 03 Mar 2021 Malvern Panalytical and Leukocare have announced an exciting collaboration aiming to improve the availability of vaccines for COVID-19. They will combine Leukocare’s pioneering expertise in biopharmaceutical formulation development with Malvern Panalytical’s extensive analytical know-how to understand how the stability of vaccines can be improved, incre...
Mark Fleiner Malvern Panalytical Andreas Seidl Malvern Panalytical Leukocare Industry News Chief Operating Officer
Source: selectscience.net